Vireo Growth Inc
OTC:VREOF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vireo Growth Inc
OTC:VREOF
|
US |
|
St Barbara Ltd
ASX:SBM
|
AU |
|
B
|
Banco de Sabadell SA
XMUN:BDSB
|
ES |
|
Uluru Co Ltd
TSE:3979
|
JP |
|
A
|
Ardentec Corp
TPEX:3264
|
TW |
|
Public Company Management Corp
OTC:PCMC
|
US |
|
C
|
Crown Holdings Inc
F:CWN
|
US |
|
S
|
Shaftesbury Capital PLC
F:C20
|
UK |
|
Arcelormittal South Africa Ltd
F:ISC1
|
ZA |
|
M
|
Microsoft Corp
DUS:MSF
|
US |
|
Smurfit WestRock PLC
F:N4U
|
IE |
|
G
|
Gen Digital Inc
XHAN:SYM
|
US |
|
F
|
Fortinet Inc
SWB:FO8
|
US |
|
Luceco PLC
F:2LC
|
UK |
Bankruptcy Probability
Vireo Growth Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vireo Growth Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Vireo Growth Inc
OTC:VREOF
|
5.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
650.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
362.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
354B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
194.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
288.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
128.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vireo Growth Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vireo Growth Inc has total debt of 429.5m USD. This includes both short-term (0 USD) and long-term (429.5m USD) debt.
You can find a full breakdown on its Balance Sheet.